The Effects and Safety of Chinese Oral Herbal Paste on Stable Chronic Obstructive Pulmonary Disease: A Systematic Review and Meta-analysis of Randomized Controlled Trials

Abstract EN

Background.

Chinese oral herbal paste has been widely used in the treatment of chronic obstructive pulmonary disease (COPD).

However, the treatment effects of herbal paste were controversial and lack evidence to support its clinical use.

This study aims to systematically assess the efficacy and safety of Chinese oral herbal paste for the treatment of stable COPD.

Methods.

PubMed, Web of Science, CENTRAL, EMBASE, CNKI, VIP, CBM, and WANFANG database in addition to two websites of clinical trial registry were searched from respective inception to August 2019.

Only randomized controlled trials (RCTs) studying Chinese herbal paste for the treatment of stable COPD were included.

Methodological quality was assessed based on Cochrane risk of bias and GRADE approach.

Data were analyzed using RevMan 5.3.

Results.

A total of 19 RCTs with 1303 individuals compared Chinese oral herbal paste and Western medicine (WM) with WM alone were included for meta-analysis.

The review showed compared with WM alone, the combination of herbal paste and WM reduced exacerbation frequency.

Subgroup analyses showed that after two to three months of treatment, compared with WM alone, Chinese herbal paste plus WM significantly decreased the St George’s Respiratory Questionnaire (SGRQ) scores, COPD assessment test (CAT) scores, and scores of traditional Chinese medicine (TCM) syndrome, and improved clinical effective rates, lung function, and 6-minute walk distance.

No serious adverse events related to herbal paste were reported.

Conclusion.

Current evidence showed that Chinese oral herbal paste may be an effective and well-tolerated adjuvant therapy for stable COPD.

Considering the risks of bias and heterogeneity, more high-quality, well-designed RCTs are still needed.